
Marcela M. Cordero Garcia
Examiner (ID: 4537)
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1654, 1676, 1658 |
| Total Applications | 1421 |
| Issued Applications | 950 |
| Pending Applications | 83 |
| Abandoned Applications | 394 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6186264
[patent_doc_number] => 20110124575
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-26
[patent_title] => 'METHOD FOR PROCESSING MICROBIOLOGICALLY PRODUCED CYCLIC OLIGOPEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 13/055715
[patent_app_country] => US
[patent_app_date] => 2009-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4862
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20110124575.pdf
[firstpage_image] =>[orig_patent_app_number] => 13055715
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/055715 | Method for processing microbiologically produced cyclic oligopeptides | Jul 28, 2009 | Issued |
Array
(
[id] => 9239188
[patent_doc_number] => 08603979
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-10
[patent_title] => 'von Willebrand factor or factor VIII and von Willebrand factor for the treatment of coagulopathy induced by inhibitors of thrombocytes'
[patent_app_type] => utility
[patent_app_number] => 13/003139
[patent_app_country] => US
[patent_app_date] => 2009-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4057
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13003139
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/003139 | von Willebrand factor or factor VIII and von Willebrand factor for the treatment of coagulopathy induced by inhibitors of thrombocytes | Jul 9, 2009 | Issued |
Array
(
[id] => 6048372
[patent_doc_number] => 20110207656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-25
[patent_title] => 'MUC1, CASPASE-8, and DED-CONTAINING PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 13/003539
[patent_app_country] => US
[patent_app_date] => 2009-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 34769
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20110207656.pdf
[firstpage_image] =>[orig_patent_app_number] => 13003539
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/003539 | MUC1, caspase-8, and DED-containing proteins | Jul 8, 2009 | Issued |
Array
(
[id] => 6163778
[patent_doc_number] => 20110160434
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-30
[patent_title] => 'FIBROMYALGIA TEST METHOD'
[patent_app_type] => utility
[patent_app_number] => 12/996649
[patent_app_country] => US
[patent_app_date] => 2009-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4363
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20110160434.pdf
[firstpage_image] =>[orig_patent_app_number] => 12996649
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/996649 | FIBROMYALGIA TEST METHOD | Jul 5, 2009 | Abandoned |
Array
(
[id] => 7702977
[patent_doc_number] => 08088731
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-01-03
[patent_title] => 'Use of GLP-1 compound for treatment of critically ill patients'
[patent_app_type] => utility
[patent_app_number] => 12/496910
[patent_app_country] => US
[patent_app_date] => 2009-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12245
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/088/08088731.pdf
[firstpage_image] =>[orig_patent_app_number] => 12496910
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/496910 | Use of GLP-1 compound for treatment of critically ill patients | Jul 1, 2009 | Issued |
Array
(
[id] => 5496340
[patent_doc_number] => 20090264368
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-22
[patent_title] => 'COMPOSITIONS FOR DELIVERING PARATHYROID HORMONE AND CALCITONIN'
[patent_app_type] => utility
[patent_app_number] => 12/496317
[patent_app_country] => US
[patent_app_date] => 2009-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7337
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20090264368.pdf
[firstpage_image] =>[orig_patent_app_number] => 12496317
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/496317 | COMPOSITIONS FOR DELIVERING PARATHYROID HORMONE AND CALCITONIN | Jun 30, 2009 | Abandoned |
Array
(
[id] => 6526947
[patent_doc_number] => 20100015058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-21
[patent_title] => 'RADIOLABELED BBN-RGD HETERODIMERS FOR CANCER TARGETING'
[patent_app_type] => utility
[patent_app_number] => 12/491905
[patent_app_country] => US
[patent_app_date] => 2009-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 47
[patent_no_of_words] => 33365
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20100015058.pdf
[firstpage_image] =>[orig_patent_app_number] => 12491905
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/491905 | RADIOLABELED BBN-RGD HETERODIMERS FOR CANCER TARGETING | Jun 24, 2009 | Abandoned |
Array
(
[id] => 5995508
[patent_doc_number] => 20110114524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-19
[patent_title] => 'STORAGE-STABLE, FUNCTIONALLY INTACT FIBRINOGEN'
[patent_app_type] => utility
[patent_app_number] => 13/000934
[patent_app_country] => US
[patent_app_date] => 2009-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5254
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0114/20110114524.pdf
[firstpage_image] =>[orig_patent_app_number] => 13000934
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/000934 | Storage-stable, functionally intact fibrinogen | Jun 21, 2009 | Issued |
Array
(
[id] => 9575256
[patent_doc_number] => 08765669
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-01
[patent_title] => 'Glycosylated GLP-1 peptide'
[patent_app_type] => utility
[patent_app_number] => 12/999654
[patent_app_country] => US
[patent_app_date] => 2009-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 30990
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12999654
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/999654 | Glycosylated GLP-1 peptide | Jun 14, 2009 | Issued |
Array
(
[id] => 5496591
[patent_doc_number] => 20090264619
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-22
[patent_title] => 'METAL-CATALYZED COPOLYMERIZATION OF IMINES AND CARBON MONOXIDE AS A ROUTE TO SYNTHESIZE POLYPEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 12/480675
[patent_app_country] => US
[patent_app_date] => 2009-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4957
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20090264619.pdf
[firstpage_image] =>[orig_patent_app_number] => 12480675
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/480675 | Metal-catalyzed copolymerization of imines and carbon monoxide as a route to synthesize polypeptides | Jun 7, 2009 | Issued |
Array
(
[id] => 9710937
[patent_doc_number] => 08835506
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-16
[patent_title] => 'Methods and related compositions for the treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 12/990334
[patent_app_country] => US
[patent_app_date] => 2009-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 8486
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12990334
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/990334 | Methods and related compositions for the treatment of cancer | Jun 4, 2009 | Issued |
Array
(
[id] => 8784680
[patent_doc_number] => 08431523
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-30
[patent_title] => 'Oligomeric biosurfactants in dermatocosmetic compositions'
[patent_app_type] => utility
[patent_app_number] => 12/995049
[patent_app_country] => US
[patent_app_date] => 2009-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15518
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 241
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12995049
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/995049 | Oligomeric biosurfactants in dermatocosmetic compositions | May 28, 2009 | Issued |
Array
(
[id] => 5373783
[patent_doc_number] => 20090311344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-17
[patent_title] => 'Dosing Regimen'
[patent_app_type] => utility
[patent_app_number] => 12/474622
[patent_app_country] => US
[patent_app_date] => 2009-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 19241
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20090311344.pdf
[firstpage_image] =>[orig_patent_app_number] => 12474622
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/474622 | Dosing Regimen | May 28, 2009 | Abandoned |
Array
(
[id] => 8784680
[patent_doc_number] => 08431523
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-30
[patent_title] => 'Oligomeric biosurfactants in dermatocosmetic compositions'
[patent_app_type] => utility
[patent_app_number] => 12/995049
[patent_app_country] => US
[patent_app_date] => 2009-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15518
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 241
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12995049
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/995049 | Oligomeric biosurfactants in dermatocosmetic compositions | May 28, 2009 | Issued |
Array
(
[id] => 9232814
[patent_doc_number] => 08598119
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-03
[patent_title] => 'Methods and compositions for sleep disorders and other disorders'
[patent_app_type] => utility
[patent_app_number] => 12/994560
[patent_app_country] => US
[patent_app_date] => 2009-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12433
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12994560
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/994560 | Methods and compositions for sleep disorders and other disorders | May 26, 2009 | Issued |
Array
(
[id] => 8017275
[patent_doc_number] => 08138140
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-20
[patent_title] => 'Self-assembling peptide amphiphiles and related methods for growth factor delivery'
[patent_app_type] => utility
[patent_app_number] => 12/466691
[patent_app_country] => US
[patent_app_date] => 2009-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12812
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/138/08138140.pdf
[firstpage_image] =>[orig_patent_app_number] => 12466691
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/466691 | Self-assembling peptide amphiphiles and related methods for growth factor delivery | May 14, 2009 | Issued |
Array
(
[id] => 8152097
[patent_doc_number] => 08168585
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-01
[patent_title] => 'Purification of peptides from colostrum'
[patent_app_type] => utility
[patent_app_number] => 12/436584
[patent_app_country] => US
[patent_app_date] => 2009-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6376
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/168/08168585.pdf
[firstpage_image] =>[orig_patent_app_number] => 12436584
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/436584 | Purification of peptides from colostrum | May 5, 2009 | Issued |
Array
(
[id] => 5485318
[patent_doc_number] => 20090275083
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-05
[patent_title] => 'ISOLATED PEPTIDES HAVING PHOSPHOLIPASE INHIBITORY ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 12/433266
[patent_app_country] => US
[patent_app_date] => 2009-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 42585
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20090275083.pdf
[firstpage_image] =>[orig_patent_app_number] => 12433266
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/433266 | Isolated peptides having phospholipase inhibitory activity | Apr 29, 2009 | Issued |
Array
(
[id] => 8104225
[patent_doc_number] => 08153761
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-04-10
[patent_title] => 'Microwave-assisted peptide synthesis'
[patent_app_type] => utility
[patent_app_number] => 12/433145
[patent_app_country] => US
[patent_app_date] => 2009-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 10
[patent_no_of_words] => 9205
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/153/08153761.pdf
[firstpage_image] =>[orig_patent_app_number] => 12433145
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/433145 | Microwave-assisted peptide synthesis | Apr 29, 2009 | Issued |
Array
(
[id] => 5367106
[patent_doc_number] => 20090304665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'Super fast-acting insulin compositions'
[patent_app_type] => utility
[patent_app_number] => 12/387225
[patent_app_country] => US
[patent_app_date] => 2009-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 87569
[patent_no_of_claims] => 140
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0304/20090304665.pdf
[firstpage_image] =>[orig_patent_app_number] => 12387225
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/387225 | Super fast-acting insulin compositions | Apr 27, 2009 | Issued |